Equistone Partners Europe Ltd. is purchasing a majority stake in German pharmaceutical wholesaler Omnicare Pharma GmbH for an undisclosed amount.
The outpatient oncology care platform is being sold by a shareholder consortium that will continue to own a stake in the company.
Omnicare Managing Director Oliver Tamimi will continue to lead the company. The deal is set to close in the fourth quarter, subject to competition authority approvals.
Equistone was advised by P+P on legal and tax, Alvarez & Marsal on commercial, Deloitte on financial, Houlihan Lokey on financing, Dechert on trust, Shearman & Sterling on legal financing, and ETS on insurance matters.
Omnicare's management team was advised by Hengeler Müller on legal and trust, BCG on commercial, KPMG on financial, EY on tax, Lincoln International on mergers and acquisitions, and Honert & Partner on MEP.